நிர்வாகி இயக்குனர் பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிர்வாகி இயக்குனர் பரிசோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிர்வாகி இயக்குனர் பரிசோதனை Today - Breaking & Trending Today

Scottish Research Centre to Open Screening Hub

Jan 18 2021 Read 3347 Times
Funding of £2.5 million is being invested in a COVID-19 drug screening and resistance hub at the MRC-University of Glasgow Centre for Virus Research (CVR) in partnership with medical research charity LifeArc, which has donated £2 million and the MRC which has provided additional funding.
The ground-breaking project, CRUSH (COVID-19 Drug-Screening and Resistance Hub), dedicated to supporting global scientific effort and accelerating vital COVID-19 antiviral innovation drug translation, will be delivered by the partners and the University of Dundee Drug Discovery Unit.
Professor Massimo Palmarini, Director of the CVR, said: “The establishment of CRUSH is an exciting development for the CVR and we are delighted to be partnering with LifeArc on this initiative. ....

Glasgow City , United Kingdom , Paul Wyatt , Massimo Palmarini , Michael Dalrymple , Glasgow Centre For Virus Research , University Of Dundee Drug Discovery Unit , University Of Dundee , Glasgow Centre , Virus Research , Resistance Hub , Dundee Drug Discovery , Executive Director Diagnostics , Science Foresight , Drug Discovery Unit , Co Vid , கிளாஸ்கோ நகரம் , ஒன்றுபட்டது கிஂக்டம் , பால் வையட் , மைக்கேல் டால்ரிம்பிள் , கிளாஸ்கோ மையம் க்கு வைரஸ் ஆராய்ச்சி , பல்கலைக்கழகம் ஆஃப் டண்டீ மருந்து கண்டுபிடிப்பு அலகு , பல்கலைக்கழகம் ஆஃப் டண்டீ , கிளாஸ்கோ மையம் , வைரஸ் ஆராய்ச்சி , எதிர்ப்பு மையம் ,

LifeArc funds COVID-19 drug screening hub at the University of Glasgow

Screening and Resistance
Hub), has received £2.5million to establish a national resource which will initially be dedicated to supporting and accelerating vital COVID-19 antiviral innovation drug translation.
The facility is funded by £2m from medical research charity LifeArc, with additional funding from the Medical Research Council. CVR CRUSH will be delivered by the University of Glasgow in collaboration with partners LifeArc and the University of Dundee Drug Discovery Unit.
Global control of the COVID-19 pandemic is dependent on the availability of effective medical treatments and vaccines. CVR CRUSH will help support the global scientific effort against the disease by providing a fully integrated hub for pre-clinical drug screening and resistance assays for SARS-CoV-2, the virus that causes COVID-19, as well as providing the same services for other dangerous and deadly viruses in high containment facilities. ....

Glasgow City , United Kingdom , Paul Wyatt , Massimo Palmarini , Fiona Watt , Michael Dalrymple , United Kingdom Research , Glasgow Centre For Virus Research , University Of Dundee Drug Discovery Unit , University Of Glasgow , Research Council , University Of Dundee , Glasgow Centre , Virus Research , Medical Research , Dundee Drug Discovery , Executive Director Diagnostics , Science Foresight , Drug Discovery Unit , Executive Chair , Medical Research Council , Kingdom Research , World Class Labs , கிளாஸ்கோ நகரம் , ஒன்றுபட்டது கிஂக்டம் , பால் வையட் ,